hypoglycemia and glp-1 on GLP-1? Here’s What You Need to Know Frontiers | The Role of
Description
The efficacy of liraglutide 3.0 mg as an adjunct to diet and exercise was also evaluated in 3731 non-diabetic patients presenting with a BMI 27 (in the presence of dyslipidemia or hypertension) or 30 kg/m 2 treated for 56 weeks

A., Ying G

To investigate whether the metabolic effects of mGIPR-Ab/GLP-1 are similar in female mice, we treated female HFD-fed Glp1r fl/fl control and Glp1r Wnt1/ mice with IP injection of either vehicle or mGIPR-Ab/P1 every 6 days for 18 days

The pharmacokinetics are optimized for weekly administration

But its not a magic bullet you order like a takeaway
What's more, we continuously measured blood glucose in rats which were administrated semaglutide from 2 h to day 14 following pMCAO, further proved the neuroprotective effects without causing a hypoglycemic episode
